SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-20-033570
Filing Date
2020-12-11
Accepted
2020-12-11 16:30:11
Documents
2
Period of Report
2020-12-10

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1564
2 EX-24 DOCUMENT attachment1.htm EX-24 2480
  Complete submission text file 0000899243-20-033570.txt   5581
Mailing Address 188 EAST BLAINE ST., SUITE 200 SEATTLE WA 98102
Business Address 188 EAST BLAINE ST., SUITE 200 SEATTLE WA 98102 206-788-4545
ALPINE IMMUNE SCIENCES, INC. (Issuer) CIK: 0001626199 (see all company filings)

IRS No.: 208969493 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451
Business Address
Hernday Natasha (Reporting) CIK: 0001780547 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37449 | Film No.: 201383834